A middle-aged man with moderate obstructive sleep apnea demonstrated clinically meaningful improvement following iNAP therapy. After two months of nightly use, apnea–hypopnea index and arousal burden decreased significantly, accompanied by marked improvement in daytime sleepiness. This case highlights iNAP as a potential non-invasive alternative for selected patient's intolerant to CPAP.
Blog Category
iNAP Therapy in a Middle-Aged Male with Moderate OSA
By taevas on 7th Jan 2026
Experience
Innovation
Firsthand
Our innovation targets the deepest challenges in healthcare, from patient discomfort to diagnostic uncertainty. We deliver breakthrough solutions that improve compliance, provide swift, accurate diagnoses, and create pathways to healing that never existed before.
Subscribe to
Taevas Perspectives
Insights on healthcare innovations, market trends & health care advancements.